Latin American Journal of Pharmacy published new progress about 2051-95-8. 2051-95-8 belongs to catalysis-chemistry, auxiliary class Carboxylic acid,Benzene,Ketone, name is 3-Benzoylpropionicacid, and the molecular formula is C10H10O3, SDS of cas: 2051-95-8.
Asif, Mohammad published the artcileIn silico activities, toxicity profiles and dug-like properties of some pyridazinyl benzenesulfonamides as a COX-inhibitor and antineoplastic agent, SDS of cas: 2051-95-8, the publication is Latin American Journal of Pharmacy (2021), 40(8), 1762-1769, database is CAplus.
This study was designed to predict in silico cyclooxygenase-2 (COX-2) inhibitory, antineoplastic activities, and toxicity profile of some benzenesulfonamide-pyridazinone derivatives, I [R = C6H5, 4-Me-C6H4, 4-Et-C6H4, etc] since COX-2 inhibitors have significant antineoplastic activity and cardiotoxicity. The result suggested that the biol. activity score has revealed that compounds I [R = 4-CO2H-C6H4, 4-CHO-C6H4, 2-anthryl] have the highest protease enzyme inhibitory activity compare to standard drug celecoxib. All the compounds follow Lipinski’s rule of 5 except celecoxib and compound I [R = 2-anthryl]. Predicted ligand-target interaction has showed that celecoxib and compound I [R = 4-Br-C6H4] have COX-2 inhibitory activity. Compounds I [R = 4-Me-C6H4, 4-Et-C6H4,4-F-C6H4,4-Cl-C6H4, 4-Br-C6H4,4-I-C6H4, 4-EtO-C6H4, 2-naphthyl] targets the cell division control protein homologies with their specific E values. The remaining compounds were carbonic anhydrase inhibitors. Compound I [R = (4-phenylphenyl)] did not show any specific targets. Celecoxib, compound I [R = 4-I-C6H4, (4-acetylphenyl)] can act on breast ductal cell carcinoma with probability value (Pa) values0.640, 0.626, and 0.625, resp. Compound I [R = 4-methylbenzohydrazide] act on glioblastoma with Pa value of 0.667. The remaining compound act on non-small cell carcinoma with compound I [R = 4-I-C6H4] has a high Pa value of 0.760. All the compounds have the probability of hERG blocking activity except compound <I [R = (4-phenylphenyl)] . Compounds I [R = C6H5, 2-naphthyl] and Celecoxib have the highest blocking probability. All the compounds are showing hepatotoxicity among them compounds I [R = 4-Et-C6H4, 4-F-C6H4, 4-MeO-C6H4, 4-EtO-C6H4, 4-NH2-C6H4, 4-CHO-C6H4, (4-acetylphenyl), (4-acetoxyphenyl), (4-carbamoylphenyl)] have the highest toxicity probability. All the compounds are Ames neg. As carbonic anhydrase enzyme is now a promising therapeutic target for cancer, the present compounds understudy may show promising activity as a COX inhibitor as well as anticancer compounds “CLC pred” results also strengthening our prediction that maximum compounds are better acting on non-small cell lung carcinoma (NSCLC).
Latin American Journal of Pharmacy published new progress about 2051-95-8. 2051-95-8 belongs to catalysis-chemistry, auxiliary class Carboxylic acid,Benzene,Ketone, name is 3-Benzoylpropionicacid, and the molecular formula is C10H10O3, SDS of cas: 2051-95-8.
Referemce:
https://courses.lumenlearning.com/boundless-chemistry/chapter/catalysis/,
Catalysis – Wikipedia